Skip to content
TrialScanner

NCT03934814

Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma

Phase 1CompletedNBPLeadMRKCollaborator

Registry record

Lead sponsor
I-Mab Biopharma US Limited
Conditions
Solid Tumor; Lymphoma
Primary completion
Jan 10, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03934814 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03934814: Study of TJ011133 in... | TrialScanner